
Long non‐coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation
Author(s) -
Yu Yingcong,
Li Linjin,
Zheng Zhiqiang,
Chen Senrui,
Chen Ende,
Hu Yiren
Publication year - 2017
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13035
Subject(s) - slug , biology , rna , microbiology and biotechnology , cancer research , suppressor , epithelial–mesenchymal transition , metastasis , cancer , gene , genetics
Gastric cancer ( GC ) remains a threat to public health with high incidence and mortality worldwide. Increasing evidence demonstrates that long non‐coding RNAs (lncRNAs) play critical regulatory roles in cancer biology, including GC . Previous profiling study showed that lnc RNA linc00261 was aberrantly expressed in GC . However, the role of linc00261 in GC progression and the precise molecular mechanism remain unknown. In this study, we report that linc00261 was significantly down‐regulated in GC tissues and the expression level of linc00261 negatively correlated with advanced tumour status and clinical stage as well as poor prognostic outcome. In vitro functional assays indicate that ectopic expression of linc00261 suppressed cell invasion by inhibiting the epithelial–mesenchymal transition ( EMT ). By RNA pull‐down and mass spectrum experiments, we identified Slug as an RNA ‐binding protein that binds to linc00261. We confirmed that linc00261 down‐regulated Slug by decreasing the stability of Slug proteins and that the tumour‐suppressive function of linc00261 can be neutralized by Slug. linc00261 may promote the degradation of Slug via enhancing the interaction between GSK 3β and Slug. Moreover, linc00216 overexpression repressed lung metastasis in vivo . Together, our findings suggest that linc00261 acts a tumour suppressor in GC by decreasing the stability of Slug proteins and suppressing EMT . By clarifying the mechanisms underlying GC progression, these findings may facilitate the development of novel therapeutic strategies for GC .